Status:

COMPLETED

Detection of Celiac Disease in Patients With Hypothyroidism

Lead Sponsor:

University of Vermont

Conditions:

Celiac Disease

Hypothyroidism

Eligibility:

All Genders

18+ years

Brief Summary

The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine i...

Detailed Description

This study is looking at whether hypothyroid patients who require above 125 mcg/day (or \>1.5mcg/kg/day) of levothyroxine are more likely to have celiac disease than those who require smaller doses. I...

Eligibility Criteria

Inclusion

  • Patients with the diagnosis of hypothyroidism that require thyroid replacement therapy.

Exclusion

  • Surgical resection of thyroid tissue, neck irradiation, radioactive iodine therapy, prior medical treatment with lithium, methimazole, propylthiouracil, ethionamide, amiodarone, or sunitinib, prior serologic testing for celiac disease.

Key Trial Info

Start Date :

March 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT01862510

Start Date

March 1 2012

End Date

December 1 2014

Last Update

December 8 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fletcher Allen Health Care

Burlington, Vermont, United States, 05405